Literature DB >> 8077613

Effect of thyroidectomy and thyroxine on hexachlorobenzene induced porphyria.

Y E Sopena de Kracoff1, A M Ferramola de Sancovich, H A Sancovich, D L Kleiman de Pisarev.   

Abstract

The role of thyroid status in hexachlorobenzene (HBC) induced porphyria was studied in normal, thyroidectomized and thyroxine (T4) treated rats. Female Wistar rats were treated with HCB for different periods of time. Serum T4 levels were depressed after 8 days of HCB administration whereas levels of triiodothyronine (T3) were not altered. T4 administered simultaneously with HCB resulted in hyperthyroxinemia. The time course of porphyrinogen carboxy-lyase (PCL) activity in the three HBC treated groups was studied. A rapid and significant decrease of PCL activity was found after 8 days of HCB treatment in T4 treated rats with respect to untreated animals. In contrast, HCB treatment of normal and thyroidectomized rats elicited a significant decrease of PCL activity after 21 and 30 days, respectively. This study shows that thyroid hormone plays an important role in the early establishment of HCB induced porphyria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077613     DOI: 10.1007/bf03348984

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria.

Authors:  D L Kleiman de Pisarev; M C Rios de Molina; L C San Martin de Viale
Journal:  Biochem Pharmacol       Date:  1990-03-01       Impact factor: 5.858

2.  Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated myelotoxicity by thyroid hormones.

Authors:  L H Hong; J D McKinney; M I Luster
Journal:  Biochem Pharmacol       Date:  1987-04-15       Impact factor: 5.858

3.  Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro and in vivo. Evidence that hexachlorobenzene is a weak Ah receptor agonist.

Authors:  M E Hahn; J A Goldstein; P Linko; T A Gasiewicz
Journal:  Arch Biochem Biophys       Date:  1989-04       Impact factor: 4.013

4.  Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.

Authors:  K Rozman; T Rozman; H Greim
Journal:  Toxicol Appl Pharmacol       Date:  1984-02       Impact factor: 4.219

5.  Effect of triiodothyronine in the regulation of haem biosynthetic pathway.

Authors:  D L Kleiman de Pisarev; A M Ferramola de Sancovich; H A Sancovich
Journal:  Acta Physiol Pharmacol Latinoam       Date:  1988

6.  Studies on the active centre of rat liver porphyrinogen carboxylase in vivo effect of hexachlorobenzene.

Authors:  S Billi de Catabbi; M C Ríos de Molina; L C San Martín de Viale
Journal:  Int J Biochem       Date:  1991

7.  Reduced serum thyroid hormone levels in hexachlorobenzene-induced porphyria.

Authors:  K Rozman; J R Gorski; P Rozman; A Parkinson
Journal:  Toxicol Lett       Date:  1986-01       Impact factor: 4.372

8.  Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunotoxicity.

Authors:  T L Pazdernik; K K Rozman
Journal:  Life Sci       Date:  1985-02-18       Impact factor: 5.037

9.  Effects of a polybrominated biphenyl mixture in the rat and mouse. I. Six-month exposure.

Authors:  B N Gupta; E E McConnell; J A Goldstein; M W Harris; J A Moore
Journal:  Toxicol Appl Pharmacol       Date:  1983-03-30       Impact factor: 4.219

10.  Epidemiology of hexachlorobenzene-induced porphyria in Turkey: clinical and laboratory follow-up after 25 years.

Authors:  H A Peters; A Gocmen; D J Cripps; G T Bryan; I Dogramaci
Journal:  Arch Neurol       Date:  1982-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.